Search

everythinglearnresearchcommunity

for

Search:↓

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Taking finasteride before surgery reduces blood loss in prostate procedures.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Tadalafil is effective for treating urinary symptoms in men with BPH.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Medical treatments for benign prostatic hyperplasia mainly relieve symptoms, while surgery is more effective but not always suitable for elderly patients.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Transplant patients often get skin problems, with treatments varying by condition.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

Corn silk extract helps reduce prostate enlargement symptoms.

A mix of Panax ginseng and bee-pollen may help prevent prostate enlargement in rats.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Minoxidil effectively treats severe hypertension, but watch for side effects.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Adrenal disorders often cause high blood pressure in young people.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Minoxidil caused a severe rash in a patient, which improved after stopping the drug.

Minoxidil doesn't increase pericardial disorder risk, but may cause fluid accumulation.